Most cancer-associated hypercalcemia cases are due to tumoral secretion of parathyroid hormone-related peptide (PTHrP) and osteolytic metastases, but a minority are caused by tumoral secretion of 1,25-dihydroxyvitamin D. Here, PTHLH is linked to Hypercalcemia.